These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29506681)

  • 1. Association of diuretic treatment at hospital discharge in patients with heart failure with all-cause short- and long-term mortality: A propensity score-matched analysis from SwedeHF.
    Parén P; Dahlström U; Edner M; Lappas G; Rosengren A; Schaufelberger M
    Int J Cardiol; 2018 Apr; 257():118-124. PubMed ID: 29506681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
    Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
    JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
    Faselis C; Arundel C; Patel S; Lam PH; Gottlieb SS; Zile MR; Deedwania P; Filippatos G; Sheriff HM; Zeng Q; Morgan CJ; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2020 Aug; 76(6):669-679. PubMed ID: 32762901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion.
    Faselis C; Lam PH; Patel S; Arundel C; Filippatos G; Deedwania P; Zile MR; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2021 Jun; 134(6):797-804. PubMed ID: 33359271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.
    Kittipibul V; Mentz RJ; Clare RM; Wojdyla DM; Anstrom KJ; Eisenstein EL; Ambrosy AP; Goyal P; Skopicki HA; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ; Greene SJ
    Eur J Heart Fail; 2024 Jul; 26(7):1518-1523. PubMed ID: 38745502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.
    Yilmaz MB; Gayat E; Salem R; Lassus J; Nikolaou M; Laribi S; Parissis J; Follath F; Peacock WF; Mebazaa A
    Eur J Heart Fail; 2011 Nov; 13(11):1244-52. PubMed ID: 22024466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.
    Ahmed A; Husain A; Love TE; Gambassi G; Dell'Italia LJ; Francis GS; Gheorghiade M; Allman RM; Meleth S; Bourge RC
    Eur Heart J; 2006 Jun; 27(12):1431-9. PubMed ID: 16709595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry.
    Mebazaa A; Motiejunaite J; Gayat E; Crespo-Leiro MG; Lund LH; Maggioni AP; Chioncel O; Akiyama E; Harjola VP; Seferovic P; Laroche C; Julve MS; Roig E; Ruschitzka F; Filippatos G;
    Eur J Heart Fail; 2018 Feb; 20(2):332-341. PubMed ID: 28990358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
    Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
    Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observation of Patients Transitioned to an Oral Loop Diuretic Before Discharge and Risk of Readmission for Acute Decompensated Heart Failure.
    Laliberte B; Reed BN; Devabhakthuni S; Watson K; Ivaturi V; Liu T; Gottlieb SS
    J Card Fail; 2017 Oct; 23(10):746-752. PubMed ID: 28688888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
    Ozierański K; Balsam P; Kapłon-Cieślicka A; Tymińska A; Kowalik R; Grabowski M; Peller M; Wancerz A; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):77-86. PubMed ID: 30649675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes.
    Miró Ò; Núñez J; Trullàs JC; Lopez-Ayala P; Llauger L; Alquézar-Arbé A; Miñana G; Mollar A; de la Espriella R; Lorenzo M; Jacob J; Espinosa B; Garcés-Horna V; Aguirre A; Fortuny MJ; Martínez-Nadal G; Gil V; Mueller C; Llorens P; ; ;
    Eur J Intern Med; 2024 Sep; 127():126-133. PubMed ID: 38763846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study.
    Cuthbert JJ; Soyiri I; Lomax SJ; Turgoose J; Fuat A; Cohen J; Clark AL
    Heart; 2024 May; 110(12):854-862. PubMed ID: 38631899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure.
    Ahmed A; Young JB; Love TE; Levesque R; Pitt B
    Int J Cardiol; 2008 Apr; 125(2):246-53. PubMed ID: 17706809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.